Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

PROMIS NEUROSCIENCES INC. (PMN) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

PROMIS NEUROSCIENCES INC. (PMN), most recent 12 months reported: net loss $42.23M. Latest balance sheet on file: liquid cash $53.46M. From SEC filings. Others in Pharmaceutical Preparations: Phio Pharmaceuticals Corp. · PROTOKINETIX, INCORPORATED · PLIANT THERAPEUTICS, INC. · Polaryx Therapeutics, Inc. · PMV PHARMACEUTICALS, INC. · PROPANC BIOPHARMA, INC. · PRAXIS PRECISION MEDICINES, INC. · Protagenic Therapeutics, Inc.\new

Stock screener

Watchlist